For healthcare professionals
The British Menopause Society (BMS) is the specialist authority for menopause and post reproductive health in the UK. Established in 1989, the BMS educates, informs and guides healthcare professionals, working in both primary and secondary care, on menopause and all aspects of post reproductive health.
Gender Language Policy
The British Menopause Society (BMS) recognises that patients have diverse gender identities. In our publications, literature, and other printed and digital materials, the BMS uses the word “woman” (and the pronouns “she” and “her”) to describe patients or individuals whose sex assigned at birth was female, whether they identify as female, male, or non-binary.
As gender language continues to evolve in the scientific and medical communities, the BMS will periodically reassess this usage and will make appropriate adjustments as necessary. When describing or referencing study populations used in research, BMS will use the gender terminology reported by the study investigators.
Education calendar overview
Principles & Practice of Menopause Care (PPMC) course
31 August 2022 - 18 September 2022
Principles & Practice of Menopause Care (PPMC) course
21 September 2022 - 9 October 2022
Menopause – The Foundations
26 September 2022
Cognitive Behaviour Therapy for menopause symptoms
29 September 2022 - 20 October 2022
Menopause – The Foundations
3 October 2022
The North American Menopause Society (NAMS) Annual Meeting
12 October 2022 - 15 October 2022
IMS 18th World Congress on Menopause
26 October 2022 - 29 October 2022
RCOG/BMS Post Reproductive Health meeting
8 November 2022 - 9 November 2022
Latest news
- New Menopause Practice Standards
- 29 June 2022
- New menopause practice standards have been launched today to help guide and support health professionals delivering menopause care. The purpose of the standards is to
- DHSC announce the appointment of Professor Dame Lesley Regan as the first Women’s Health Ambassador
- 17 June 2022
- The British Menopause Society congratulates Professor Dame Lesley Regan on her historic appointment as the government’s first ever Women’s Health Ambassador for England. Dame Lesley
- BMJ Editorial: Looking at HRT in perspective - Helping women make informed choices
- 16 June 2022
- An editorial Looking at HRT in perspective - Helping women make informed choices by Haitham Hamoda and Sara Moger, was published today in the BMJ.
- BMS statement on over-the-counter menopause tests
- 10 June 2022
- The British Menopause Society (BMS) does not recommend over-the-counter menopause tests. They are not a good method of detecting menopause or perimenopause. Haitham Hamoda, Chair
Bioidentical HRT
The full BMS Consensus Statement on Bioidentical HRT is available to non-Members.
Our patient arm
Women’s Health Concern (WHC), established in 1972 and the patient arm of the BMS since 2012. WHC provides a confidential, independent service to advise, inform and reassure women about their gynaecological, sexual and post reproductive health.
Affiliations
The British Menopause Society is a specialist society associated with the Royal College of Obstetricians and Gynaecologists.
This site complies to the HONcode standard for trustworthy health information. Verify here |
Website last reviewed: